ESR1 and breast cancer: In a previously published study by Mavaddat et al. in 2019, the authors developed BC PRSs optimized for the prediction of estrogen receptor-specific BC, utilizing a large collaborative effort involving 94,075 BC positive cases and 75,017 BC negative controls of European ancestry genotyped on the iCOGS and OncoArray following 1000 genomes imputation [17].